Loading...
Targeting angiogenesis in advanced cervical cancer
Patients with advanced stage or recurrent cervical cancer represent a population with limited chemotherapeutic options. More specifically, patients with recurrent disease have a poor salvage rate, with a 5-year survival rate of less than 10%. This year, the first prospective phase III clinical trial...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4206649/ https://ncbi.nlm.nih.gov/pubmed/25364393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834014543794 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|